Next Article in Journal
Mesenchymal Stem/Stromal Cell Production Compliant with Good Manufacturing Practice: Comparison between Bone Marrow, the Gold Standard Adult Source, and Wharton’s Jelly, an Extraembryonic Source
Previous Article in Journal
The Level of FGF 21 as a New Risk Factor for the Occurrence of Cardiometabolic Disorders amongst the Psoriatic Patients
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
JCM
Volume 8
Issue 12
10.3390/jcm8122208
jcm-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Near-Infrared Spectroscopy Monitoring in Cardiac and Noncardiac Surgery: Pairwise and Network Meta-Analyses

by
Christian Ortega-Loubon
1,2,
Francisco Herrera-Gómez
2,3,4,*,
Coralina Bernuy-Guevara
3,
Pablo Jorge-Monjas
2,5,6,
Carlos Ochoa-Sangrador
7,
Juan Bustamante-Munguira
1,
Eduardo Tamayo
2,5,6 and
F. Javier Álvarez
2,3,8
1
Department of Cardiac Surgery, University Clinical Hospital of Valladolid, Ramon y Cajal Ave. 3, 47003 Valladolid, Spain
2
BioCritic. Group for Biomedical Research in Critical Care Medicine, Ramon y Cajal Ave. 7, 47005 Valladolid, Spain
3
Pharmacological Big Data Laboratory, Department of Pharmacology and Therapeutics, University of Valladolid, Ramon y Cajal Ave. 7, 47005 Valladolid, Spain
4
Department of Anatomy and Radiology, Faculty of Medicine, University of Valladolid, Ramon y Cajal Ave. 7, 47005 Valladolid, Spain
5
Department of Anaesthesiology, University Clinical Hospital of Valladolid, Ramon y Cajal Ave. 3, 47003 Valladolid, Spain
6
Department of Surgery, Faculty of Medicine, University of Valladolid, Ramon y Cajal Ave. 7, 47005 Valladolid, Spain
7
Clinical Epidemiology Support Office, Sanidad Castilla y León, Requejo Ave. 35, 49022 Zamora, Spain
8
Ethics Committee of Drug Research–East Valladolid, University Clinical Hospital of Valladolid, Ramon y Cajal Ave. 3, 47003 Valladolid, Spain
*
Author to whom correspondence should be addressed.
J. Clin. Med. 2019, 8(12), 2208; https://doi.org/10.3390/jcm8122208
Submission received: 5 December 2019 / Accepted: 11 December 2019 / Published: 14 December 2019
(This article belongs to the Section Anesthesiology)
Browse Figures
Review Reports Versions Notes

Abstract

:
Goal-directed therapy based on brain-oxygen saturation (bSo2) is controversial and hotly debated. While meta-analyses of aggregated data have shown no clinical benefit for brain near-infrared spectroscopy (NIRS)-based interventions after cardiac surgery, no network meta-analyses involving both major cardiac and noncardiac procedures have yet been undertaken. Randomized controlled trials involving NIRS monitoring in both major cardiac and noncardiac surgery were included. Aggregate-level data summary estimates of critical outcomes (postoperative cognitive decline (POCD)/postoperative delirium (POD), acute kidney injury, cardiovascular events, bleeding/need for transfusion, and postoperative mortality) were obtained. NIRS was only associated with protection against POCD/POD in cardiac surgery patients (pooled odds ratio (OR)/95% confidence interval (CI)/I2/number of studies (n): 0.34/0.14–0.85/75%/7), although a favorable effect was observed in the analysis, including both cardiac and noncardiac procedures. However, the benefit of the use of NIRS monitoring was undetectable in Bayesian network meta-analysis, although maintaining bSo2 > 80% of the baseline appeared to have the most pronounced impact. Evidence was imprecise regarding acute kidney injury, cardiovascular events, bleeding/need for transfusion, and postoperative mortality. There is evidence that brain NIRS-based algorithms are effective in preventing POCD/POD in cardiac surgery, but not in major noncardiac surgery. However, the specific target bSo2 threshold has yet to be determined.

1. Introduction

Serious repercussions of cardiac and noncardiac procedures, including acute kidney injury (AKI) [1,2,3], respiratory complications [4], postsurgical bleeding [5], and major adverse cardiovascular events (MACE), such as stroke [6] and acute myocardial infarction [7], are still common [8]. Neurological events, including postoperative cognitive decline (POCD) and postoperative delirium (POD), are some of the most important complications [9,10], increasing healthcare costs by 40% of these patients [11] and enormously impairing their quality of life [6,12].
The etiology of these complications is multifactorial and poorly understood. Thus, patients need to be closely monitored [13]. Near-infrared spectroscopy (NIRS) is a promising technique that continuously maintains oxygen saturation within a regional tissue area [14]. Despite the cerebral benefits of brain-oxygen-saturation (bSo2) monitoring [15], whether NIRS should be a standard of care remains hotly debated [16,17]. It is not yet routine [18] and is still regarded as an insufferable parameter to monitor by anesthesiologists [19]. The central nervous system is rarely directly monitored and is often managed through indirect variables [9].
The scarcity of evidence regarding the clinical benefits of NIRS leads to uncertainty in its use. We hypothesize that bSo2 monitoring may reduce the incidence of major postoperative adverse outcomes, including POCD/POD, MACEs, AKI, bleeding/need for transfusion, and mortality, in patients undergoing cardiac and noncardiac surgery. To tackle this controversy, taking into account the fact that different NIRS target values have never been compared head to head in either randomized controlled trials (RCTs) or currently available meta-analyses, we conducted conventional pairwise and network meta-analyses to evaluate the effectiveness of individualized NIRS-based measures in decreasing the occurrence of these clinical outcomes.

2. Materials and Methods

2.1. Systematic Review Process

Internet database-specific search strategies were developed and applied to MEDLINE, EMBASE, and the Cochrane Controlled Register of Trials (CENTRAL), as well as study registries, repositories, and meeting abstracts archives up to April 2019 (Supplementary Methods). According to study eligibility (Table 1), 1 reviewer initially scanned the results to exclude clearly irrelevant studies. Thereafter, 2 reviewers independently evaluated titles, abstracts, and full-text reports (conciliation and corresponding author contact were planned).

2.2. Statistical Analysis

After assessing study quality [20], and before applying planned contextualization techniques [21,22,23], pairwise and network meta-analyses of cardiac- and noncardiac-surgery-patient aggregate-level data were performed. The overall odds ratio (OR) and 95% confidence interval (CI) were obtained for various postoperative outcomes corresponding to the use of NIRS monitoring (POCD/POD, MACEs, AKI, bleeding/need for transfusion, and mortality) by the Mantel–Haenszel random-effects method. The heterogeneity and presence of reporting bias was verified using Review Manager (RevMan) software version 5.3 (Cochrane Collaboration, Copenhagen, Denmark). Pooled ORs, with their corresponding 95% credible intervals (95% CrIs) for the aforementioned outcomes, were also calculated via Bayesian network meta-analysis (Markov chain Monte Carlo simulation on vague priors using a random-effects model for ‘bad’ outcomes and 0 values correction). They were presented in league tables with a calculation of the surface under the cumulative ranking area (SUCRA) for various competing NIRS target values (bSo2 > 70%/75%/80%/85%, and nondrop bSo2 > 15%/20% from baseline), after verifying convergence and inconsistency using NetMetaXL software (Canadian Agency for Drugs and Technologies in Health, Ottawa, Canada, and Cornerstone Research Group, Ontario, Canada) [24]. The Grades of Recommendation, Assessment, Development, and Evaluation (GRADE) approach was used for rating the confidence of the obtained effect estimates [20].

3. Results

Results of the pairwise and network meta-analyses were presented according to the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) extension statement for the reporting of systematic reviews that incorporated network meta-analyses of healthcare interventions [25] and that followed a registered protocol in the International Prospective Register of Systematic Reviews (PROSPERO; registration ID: CRD42019131417). This ensured study suitability in terms of nonredundancy, transparency, and adequacy of the chosen methods (prospective recording of the planned review details) [26].

3.1. Study Characteristics

After the search process, step-by-step results, which are presented graphically in the standard flowchart provided by the PRISMA group (Figure 1) [27], a total of 12 RCTs were eligible [28,29,30,31,32,33,34,35,36,37,38,39]. They involved a total population of 1626 major surgery patients (cardiac and noncardiac surgical procedures). The details of the participants, interventions, comparators, main and secondary outcomes, and key features of eligible studies (RCT design details, follow-up data) are available in tabular form (Table S1). The same information is also accessible online in tabular form for three eligible RCTs [19,40,41] that were excluded because of a lack of numerical data for the dichotomous analysis of the planned outcome (Table S2). Overall, all of these studies presented evidence for the use of NIRS in the last 15 years and involved clinical activity in developing and developed countries from all over the world. All of these studies were reported as peer-reviewed journal articles in highly ranked Journal Citation Reports (JCR) journals. No unpublished reports corresponding to these studies were found, nor were other unpublished studies available.
Other excluded records consisted of observational studies, case series of patients who underwent major surgery and opinion, or narrative review articles focused particularly on the cardiac-surgery-patient population. Interestingly, on average, 10% of the reports presenting noninterventional data were available as unpublished reports (oral and posted abstracts presented in relevant international meetings).
According to the within-study risk of bias assessment, the methodological quality of eligible studies was considered moderate to high (Table S3). Importantly, POCD/POD was reported with a high lack of harmony (i.e., various scoring systems were used), and with the rationale that it would not be clinically relevant. However, when separately examining the articles, all of the studies suggested a relationship between the use of NIRS monitoring and improved outcomes in study participants who did not undergo the comparators. The risk of selective reporting bias was high when the sample size was taken into account.

3.2. Outcomes

In the pairwise meta-analyses of cardiac- and noncardiac-surgery patients (all cardiac-surgery patients underwent cardiopulmonary bypass), in seven and three of the 12 eligible RCTs, respectively (Figure 2), the pooled ORs and 95% CIs for the outcome of POCD/POD were 0.34 (0.14 to 0.85) and 0.33 (0.10 to 1.14). Overall, for cardiac- and noncardiac-surgery patients, the OR and 95% CI for this outcome was in favor of intervention, at 0.34 (0.17 to 0.67). Importantly, no heterogeneity in subgroup comparisons, and critical funnel-plot asymmetry affecting these summary estimates, was observed. In addition, the benefit of the use of NIRS monitoring was undetectable in the Bayesian network meta-analysis. No superiority of any NIRS target values in any of the 10 trials included in analysis was noted (Figure 3). Interestingly, on the basis of SUCRA, with respect to other target values, maintaining bSo2 > 80% of baseline appeared to have the most pronounced impact on the outcome of POCD/POD. This was true even when considering the influence of heterogeneity (vague priors) on network-diagram geometry (Figure 4A), which was counterbalanced by the absence of inconsistency (Figure 4B).
According to GRADE, effect estimates for this outcome should be considered as derived from a low-quality body of evidence. The quality rating fell by two levels for heterogeneity and risk of reporting bias, even considering that there was no influence of indirectness in participants, interventions, comparators, outcomes, or imprecision in summary estimates (acceptably wide CIs except in the subgroup of noncardiac-surgery patients).
In the pairwise meta-analysis of five, six, six, and two trials out of the 12 eligible RCTs, the pooled OR and 95% CI for outcomes of postoperative mortality, MACEs, AKI, and bleeding/need for transfusion were 0.58 (0.22 to 1.50), 0.47 (0.20 to 1.10), 0.69 (0.43 to 1.12), and 0.43 (0.10 to 1.94), respectively. Interestingly, when analyzing data on morbidity (combination of POCD/POD, MACEs, and AKI), the OR and 95% CI were 0.41 (0.25 to 0.70). These calculations were not affected by heterogeneity (I2 = 0%, p > 0.1), with the exception of bleeding/need for transfusion (I2 = 82%, p = 0.02) and the combined outcome of morbidity (I2 = 67%, p = 0.0004). However, funnel-plot asymmetry was evident (Figures S1 to S5). Remarkably, in Bayesian network meta-analysis, maintaining a higher bSo2 (>75–80%) relative to baseline, rather than avoiding a drop in bSo2, appeared to have the most pronounced impact on outcomes of postoperative mortality, MACEs, and AKI according to the SUCRA-based ranking (Table S4). This was true even when considering heterogeneity that was compensated for by freedom from inconsistency (Figures S6 and S7).
With the exception of bleeding/need for transfusion, effect estimates for the remaining outcomes should be considered as derived from a low-quality body of evidence according to GRADE. This is taking into account the imprecision of pooled estimates (wide CIs) and risk of reporting bias. Heterogeneity, risk of reporting bias, and imprecision downgraded the quality for the outcome of bleeding/need for transfusion to very low.

4. Discussion

4.1. Major Findings

This systematic review and meta-analysis demonstrated reductions in POCD/POD, attributable to the use of individualized NIRS-based interventions only during major cardiac surgery and not major noncardiac surgery. While maintaining bSo2 > 80% of the baseline appeared to be a safety threshold, the specific bSo2 threshold resulting in the greatest clinical benefit is yet to be determined. In addition, the use of NIRS monitoring did not result in an occurrence reduction of AKI, cardiovascular events, bleeding/need for transfusion, or postoperative mortality.

4.2. Strengths and Limitations

This is the first summary of evidence applying and presenting the findings of analysis allowing for the comparison of methodologically independent exposures (i.e., several NIRS target values) that have not been previously assessed for critical outcomes in the context of major surgery. To date, only conventional pairwise meta-analysis techniques and qualitative synthesis of skewed data have been performed [11,42]. Conventional pairwise meta-analysis is insufficient when many options for tools (interventions) exist (e.g., when several drugs are available for the same treatment strategy). Network meta-analysis provides a viable solution, even though some interventions/exposures have never been compared head to head in RCTs [21]. Furthermore, to the best of our knowledge, this is the first contemporary review of NIRS monitoring in both types of major procedures.
Although the comprehensiveness of searches is guaranteed, the risk of reporting bias (funnel-plot asymmetry) is more of a concern than the mathematical confirmation of missing more imprecise studies (probably unpublished) in analyses [43,44]. Reporting bias can lead to overly optimistic conclusions in systematic reviews [45]. Likewise, statistical heterogeneity, mainly related to inherent differences between major cardiac- and noncardiac-surgery patients, reduces the generalizability of the findings of this meta-analysis [46]. This is true even for subgroup analyses that were performed [47]. There were no trials in pediatric cardiac surgery, which is a common setting for the use of this technology. Thus, relevant information was missed regarding the benefits of this monitoring method in the pediatric population. Furthermore, while POCD/POD may be part of a continuum, they may have different implications. Thus, they may be considered separately.

4.3. Clinical Implications

POD has been shown to be associated with a longer and costlier hospital course, a higher likelihood of death within six months, and postoperative institutionalization. Similarly, POCD has been related to increased mortality, poor quality of life, higher risk of prematurely leaving the work force, and increased dependence on social transfer payments [48].
Moreover, POCD/POD is especially common in elderly patients, given that advanced age is an acknowledged risk factor for its development. This bears severe and long-lasting consequences for these patients [49]. With aging global populations, an increasing number of both cardiac and noncardiac procedures, and scarcity in available therapeutic alternatives for POCD/POD, timely measures directed towards its prevention remain an issue of paramount importance [50]. In this regard, Lei et al. reported that low preoperative bSo2 may be related to an increased frequency of POD after cardiac surgery in patients >60 years old [51]. Similarly, Radtke and colleagues showed that intraoperative neuromonitoring was associated with lower rates of POD in high-risk surgical patients [52].
The results of this systematic review not only support the hypothesis that cerebral NIRS-based algorithms can prevent POCD/POD, but also substantially strengthen the clinical basis for the use of NIRS monitoring in cardiac surgery. This work supports a large number of reports that revealed NIRS as an early detector of regional oxygen metabolism imbalance [30,33,34,41,53].
This technology has also been used in other settings, such as discrimination between stable and unstable atherosclerotic plaques [54], the diagnosis and treatment of depression, schizophrenia, and Alzheimer’s disease [55], and the assessment of tissue perfusion in neonates [56]. Subsequent actions performed by already standardized algorithms to prevent bSo2 desaturation could prevent long-lasting and devastating complications [30,33,36,40]. Reductions in NIRS values have been used to promptly identify devastating cerebral events, while more invasive monitoring metrics remain unchanged [19,57,58].
Although bSo2 monitoring is routinely performed in many cardiac-surgery centers, it is not a universally standardized practice, and has recently been used in specific major noncardiac surgeries [9,29,31]. In orthopedic surgery, for instance, this technology has been exclusively used in patients undergoing shoulder surgery in the beach-chair position [32,59,60]. This could be a reason why there is insufficient evidence to support its use in this type of procedure. Only four out of 12 RCTs included in this meta-analysis examined the effects of NIRS-based interventions in noncardiac surgery.
Similar to this study, Chan et al. performed meta-analysis and identified that reference bSo2 baseline values in cardiac surgery widely vary [61]. They found that preoperative bSo2 values are quite heterogeneous, and that there is a lack of knowledge of postoperative changes in bSo2. This might explain the considerable heterogeneity among general NIRS data reported in studies [62]. Indeed, each RCT arbitrarily defined their specific NIRS-based algorithms, making analysis highly complex, and significantly reducing the chance of identifying the target bSo2 threshold with the greatest clinical value in terms of lowering the risk of POCD/POD, AKI, and postoperative mortality. Nonetheless, maintaining bSo2 > 80% of the baseline seems to yield the best results.
It is clear that, without feedback from a specific indicator of end-organ damage, i.e., bSo2, the capacity to detect and enhance otherwise silent but potentially catastrophic perturbations with clinical variables remains significantly restricted [36]. Thus, NIRS monitors should be considered an essential component of generally accepted intraoperative monitoring in cardiac surgery. The implementation of such a simple measure, for instance, as a further essential requirement of the World Health Organization Safer Surgery checklist before and during surgery, may minimize the occurrence of adverse outcomes [63]. Adaptation of the checklist might help to avoid complications with devastating consequences such as POCD.
The capacity of brain-injury biomarkers to predict or prevent POCD/POD in a timely manner is considerably restricted, as they are relatively nonspecific and inconclusive. Neuron-specific enolase (NSE) is an intracellular enzyme found in neurons, neuroendocrine cells, platelets, and erythrocytes [64]. S-100B is expressed in adipose tissue and the thymus [65]. An initial elevation in S-100B levels due to brain injury occurs at least 24 h after surgery [65]. S-100 release is biphasic, starting three to five hours after brain injury and occurring a second time 48 h after the insult [66]. S-100B shows a similar pattern. The peak level of S-100B occurs on the third day following a stroke. The cerebrospinal fluid levels of S-100 and S-100B are more accurate than the serum levels of S-100 and S-100B for evaluating cerebral damage [66]. However, these samples are limited [65]. Furthermore, they cannot be continuously assessed [28,37,67], and generally require a substantial amount of money to assess [64]. Thus, no optimal markers have emerged with regards to specificity or predictive value [68].
Conversely, the results presented here do not support the hypothesis that the use of bSo2 monitoring, using the brain as the index organ, reduces injury to the heart, kidneys, or lungs, or reduces mortality as a result of improved overall perfusion during cardiac or noncardiac surgery. This is similar to the conclusions of other authors [37,38,42]. This could be explained by cerebral autoregulation, which ensures relatively constant brain blood flow, even in cases of poor systemic perfusion. Olbrecht and colleagues showed that bSo2 remains unchanged in low-arterial-pressure events [69]. Furthermore, Chan et al. detected a lack of evidence for the correlation between bSo2 changes and postoperative outcomes because almost all studies have only focused on the intraoperative stage. This has left an unexplored gap in the postoperative period, where NIRS dynamics is also vital and may help to further understand clinical consequences [61]. Ortega-Loubon et al. demonstrated that postoperative kidney oxygen saturation (kSo2), but neither intraoperative kSo2 nor bSo2, was correlated with the occurrence of postoperative AKI [14,70]. Therefore, it may be necessary to more closely monitor susceptible organs that are more likely to suffer acute injury during and after major procedures.

5. Conclusions

Existing evidence suggests that the use of patient-specific NIRS-based algorithms that aim to maintain bSo2 during cardiac surgery result in a reduction in the occurrence of POCD/POD, but not AKI, cardiovascular events, bleeding/need for transfusion, or postoperative mortality. Aiming to maintain bSo2 > 80% of the baseline seems to yield the maximum benefit in terms of preventing POCD/POD in cardiac surgery. This analysis contributes to the debate regarding the use of NIRS monitoring, at least in cardiac surgery. To address unanswered questions, further clinical trials of countermeasures against adverse outcomes after major noncardiac procedures are needed.

Supplementary Materials

The following are available online at https://www.mdpi.com/2077-0383/8/12/2208/s1, Material S1: Supplementary methods and search strategy; Table S1: Participants, interventions, comparators, and outcomes in the included trials; Table S2: Participants, interventions, comparators, and outcomes in trials eligible but not providing numerical data for the analysis; Table S3: Assessing risk of bias in trials eligible; Table S4: The ranking of SUCRA assessable NIRS target values for three outcomes; Figure S1: The effect of NIRS monitoring on post-operative death; Figure S2: The effect of NIRS monitoring on post-operative AKI; Figure S3: The effect of NIRS monitoring on MACEs; Figure S4: The effect of NIRS monitoring on bleeding/need for transfusions; Figure S5: The effect of NIRS monitoring on morbidity combining POCD/POD, AKI and MACEs; Figure S6: Network forests plot of the random effects (vague priors) for the SUCRA assessable NIRS target values corresponding to (A) post-operative death, (B) post-operative AKI, and (C) MACEs; Figure S7: Inconsistency plot of the random effects for the SUCRA assessable NIRS target values corresponding to (A) post-operative death, (B) post-operative AKI, and (C) MACEs.

Author Contributions

Conceptualization, F.J.Á., F.H.-G., C.O.-L., and E.T.; data curation, C.B.-G. and F.H.-G.; formal analysis, C.B.-G. and F.H.-G.; funding acquisition, F.J.Á.; investigation, C.B.-G., F.H.-G., C.O.-S., and C.O.-L.; methodology, F.H.-G. and C.O.-S.; project administration, F.J.Á., J.B.-M., F.H.-G., and E.T.; resources, F.J.Á., F.H.-G., and C.O.-L.; software, F.H.-G.; supervision, F.J.Á. and E.T.; validation, P.J.-M., C.O.-L., and E.T.; visualization, F.J.Á., F.H.-G., and C.O.-L.; writing—original draft, C.B.-G., F.H.-G., and C.O.-L.; writing—review and editing, F.J.Á., F.H.-G., P.J.-M., C.O.-L., and C.O.-S., C.O.-L. and F.H.-G. are cofirst authors. F.J.Á. and E.T. are cosenior authors.

Funding

This research received no external funding.

Acknowledgments

The authors thank Consejería de Educación, Junta de Castilla y León, Spain (reference: VA161G18) for covering the publication charges of this article.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Ortega-Loubon, C.; Fernandez-Molina, M.; Carrascal-Hinojal, Y.; Fulquet-Carreras, E. Cardiac surgery-associated acute kidney injury. Ann. Card. Anaesth. 2016, 19, 687–698. [Google Scholar] [CrossRef] [PubMed]
  2. Ortega-Loubon, C.; Fernandez-Molina, M.; Paneda-Delgado, L.; Jorge-Monjas, P.; Carrascal, Y. Predictors of Postoperative Acute Kidney Injury after Coronary Artery Bypass Graft Surgery. Braz. J. Cardiovasc. Surg. 2018, 33, 323–329. [Google Scholar] [CrossRef] [PubMed]
  3. Goren, O.; Matot, I. Perioperative acute kidney injury. Br. J. Anaesth. 2015, 115, ii3–ii14. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  4. Weissman, C. Pulmonary complications after cardiac surgery. Semin. Cardiothorac. Vasc. Anesth. 2004, 8, 185–211. [Google Scholar] [CrossRef] [PubMed]
  5. Ranucci, M.; Baryshnikova, E.; Pistuddi, V.; Menicanti, L.; Frigiola, A.; Surgical and Clinical Outcome REsearch (SCORE) Group. The effectiveness of 10 years of interventions to control postoperative bleeding in adult cardiac surgery. Interact. Cardiovasc. Thorac. Surg. 2017, 24, 196–202. [Google Scholar] [CrossRef] [Green Version]
  6. Selnes, O.A.; Gottesman, R.F.; Grega, M.A.; Baumgartner, W.A.; Zeger, S.L.; McKhann, G.M. Cognitive and neurologic outcomes after coronary-artery bypass surgery. N. Engl. J. Med. 2012, 366, 250–257. [Google Scholar] [CrossRef] [PubMed]
  7. Cubero-Gallego, H.; Lorenzo, M.; Heredia, M.; Gomez, I.; Tamayo, E. Diagnosis of perioperative myocardial infarction after heart valve surgery with new cut-off point of high-sensitivity troponin T and new electrocardiogram or echocardiogram changes. J. Thorac. Cardiovasc. Surg. 2017, 154, 895–903. [Google Scholar] [CrossRef] [Green Version]
  8. Lomivorotov, V.V.; Efremov, S.M.; Kirov, M.Y.; Fominskiy, E.V.; Karaskov, A.M. Low-Cardiac-Output Syndrome After Cardiac Surgery. J. Cardiothorac. Vasc. Anesth. 2017, 31, 291–308. [Google Scholar] [CrossRef]
  9. Casati, A.; Fanelli, G.; Pietropaoli, P.; Proietti, R.; Tufano, R.; Danelli, G.; Fierro, G.; De Cosmo, G.; Servillo, G. Continuous monitoring of cerebral oxygen saturation in elderly patients undergoing major abdominal surgery minimizes brain exposure to potential hypoxia. Anesth. Analg. 2005, 101, 740–747. [Google Scholar] [CrossRef]
  10. Newman, S.; Stygall, J.; Hirani, S.; Shaefi, S.; Maze, M. Postoperative cognitive dysfunction after noncardiac surgery: A systematic review. Anesthesiology 2007, 106, 572–590. [Google Scholar] [CrossRef]
  11. Serraino, G.F.; Murphy, G.J. Effects of cerebral near-infrared spectroscopy on the outcome of patients undergoing cardiac surgery: A systematic review of randomised trials. BMJ Open 2017, 7, e016613. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  12. Crosby, G.; Culley, D.J.; Dexter, F. Cognitive outcome of surgery: Is there no place like home? Anesth. Analg. 2014, 118, 898–900. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  13. Ortega-Loubon, C.; Fernandez-Molina, M.; Jorge-Monjas, P.; Fierro, I.; Herrera-Calvo, G.; Tamayo, E. The Relevance of Renal Oxygen Saturation Over Other Markers in Cardiac Surgery-Associated Acute Kidney Injury. J. Cardiothorac. Vasc. Anesth. 2018. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  14. Ortega-Loubon, C.; Fernandez-Molina, M.; Fierro, I.; Jorge-Monjas, P.; Carrascal, Y.; Gomez-Herreras, J.I.; Tamayo, E. Postoperative kidney oxygen saturation as a novel marker for acute kidney injury after adult cardiac surgery. J. Thorac. Cardiovasc. Surg. 2018. [Google Scholar] [CrossRef] [PubMed]
  15. Mailhot, T.; Cossette, S.; Lambert, J.; Cournoyer, A.; Denault, A.Y. Cerebral oximetry as a biomarker of postoperative delirium in cardiac surgery patients. J. Crit. Care 2016, 34, 17–23. [Google Scholar] [CrossRef] [PubMed]
  16. Bevan, P.J. Should Cerebral Near-infrared Spectroscopy be Standard of Care in Adult Cardiac Surgery? Heart Lung Circ. 2015, 24, 544–550. [Google Scholar] [CrossRef]
  17. Hirsch, J.C.; Charpie, J.R.; Ohye, R.G.; Gurney, J.G. Near infrared spectroscopy (NIRS) should not be standard of care for postoperative management. Semin. Thorac. Cardiovasc. Surg. 2010, 13, 51–54. [Google Scholar] [CrossRef]
  18. Tweddell, J.S.; Ghanayem, N.S.; Hoffman, G.M. Pro: NIRS is “standard of care” for postoperative management. Semin. Thorac. Cardiovasc. Surg. 2010, 13, 44–50. [Google Scholar] [CrossRef]
  19. Deschamps, A.; Lambert, J.; Couture, P.; Rochon, A.; Lebon, J.S.; Ayoub, C.; Cogan, J.; Denault, A. Reversal of decreases in cerebral saturation in high-risk cardiac surgery. J. Cardiothorac. Vasc. Anesth. 2013, 27, 1260–1266. [Google Scholar] [CrossRef] [Green Version]
  20. The Cochrane Collaboration. Assessing risk of bias in included studies. In Cochrane Handbook for Systematic Reviews of Interventions—Version 5.1.0.; Higgins, J.P.T., Ed.; John Wiley & Sons: Copenhagen, Denmark, 2011. [Google Scholar]
  21. Herrera-Gomez, F.; Chimeno, M.M.; Martin-Garcia, D.; Lizaraso-Soto, F.; Maurtua-Briseno-Meiggs, A.; Grande-Villoria, J.; Bustamante-Munguira, J.; Alamartine, E.; Vilardell, M.; Ochoa-Sangrador, C.; et al. Cholesterol-Lowering Treatment in Chronic Kidney Disease: Multistage Pairwise and Network Meta-Analyses. Sci. Rep. 2019, 9, 8951. [Google Scholar] [CrossRef] [Green Version]
  22. Herrera-Gomez, F.; Del Aguila, W.; Tejero-Pedregosa, A.; Adler, M.; Padilla-Berdugo, R.; Maurtua-Briseno-Meiggs, A.; Pascual, J.; Pascual, M.; San Segundo, D.; Heidt, S.; et al. The number of FoxP3 regulatory T cells in the circulation may be a predictive biomarker for kidney transplant recipients: A multistage systematic review. Int. Immunopharmacol. 2018, 65, 483–492. [Google Scholar] [CrossRef] [PubMed]
  23. Herrera-Gomez, F.; Monge-Donaire, D.; Ochoa-Sangrador, C.; Bustamante-Munguira, J.; Alamartine, E.; Alvarez, F.J. Correction of Hyponatremia May Be a Treatment Stratification Biomarker: A Two-Stage Systematic Review and Meta-Analysis. J. Clin. Med. 2018, 7, 262. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  24. Brown, S.; Hutton, B.; Clifford, T.; Coyle, D.; Grima, D.; Wells, G.; Cameron, C. A Microsoft-Excel-based tool for running and critically appraising network meta-analyses—an overview and application of NetMetaXL. Syst. Rev. 2014, 3, 110. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  25. Hutton, B.; Salanti, G.; Caldwell, D.M.; Chaimani, A.; Schmid, C.H.; Cameron, C.; Ioannidis, J.P.; Straus, S.; Thorlund, K.; Jansen, J.P.; et al. The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: Checklist and explanations. Ann. Intern. Med. 2015, 162, 777–784. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  26. Shamseer, L.; Moher, D.; Clarke, M.; Ghersi, D.; Liberati, A.; Petticrew, M.; Shekelle, P.; Stewart, L.A.; Group, P.-P. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: Elaboration and explanation. BMJ 2015, 350, g7647. [Google Scholar] [CrossRef] [Green Version]
  27. Moher, D.; Liberati, A.; Tetzlaff, J.; Altman, D.G.; Group, P. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. Ann. Intern. Med. 2009, 6, e1000097. [Google Scholar] [CrossRef]
  28. Ballard, C.; Jones, E.; Gauge, N.; Aarsland, D.; Nilsen, O.B.; Saxby, B.K.; Lowery, D.; Corbett, A.; Wesnes, K.; Katsaiti, E.; et al. Optimised anaesthesia to reduce post operative cognitive decline (POCD) in older patients undergoing elective surgery, a randomised controlled trial. PLoS ONE 2012, 7, e37410. [Google Scholar] [CrossRef]
  29. Casati, A.; Fanelli, G.; Pietropaoli, P.; Proietti, R.; Tufano, R.; Montanini, S. Monitoring cerebral oxygen saturation in elderly patients undergoing general abdominal surgery: A prospective cohort study. Eur. J. Anaesthesiol. 2007, 24, 59–65. [Google Scholar] [CrossRef]
  30. Colak, Z.; Borojevic, M.; Bogovic, A.; Ivancan, V.; Biocina, B.; Majeric-Kogler, V. Influence of intraoperative cerebral oximetry monitoring on neurocognitive function after coronary artery bypass surgery: A randomized, prospective study. Eur. J. Cardiothorac. Surg. 2015, 47, 447–454. [Google Scholar] [CrossRef] [Green Version]
  31. Cowie, D.A.; Nazareth, J.; Story, D.A. Cerebral oximetry to reduce perioperative morbidity. Anaesth. Intensive Care 2014, 42, 310–314. [Google Scholar] [CrossRef] [Green Version]
  32. Cox, R.M.; Jamgochian, G.C.; Nicholson, K.; Wong, J.C.; Namdari, S.; Abboud, J.A. The effectiveness of cerebral oxygenation monitoring during arthroscopic shoulder surgery in the beach chair position: A randomized blinded study. J. Shoulder Elbow. Surg. 2018, 27, 692–700. [Google Scholar] [CrossRef] [PubMed]
  33. Deschamps, A.; Hall, R.; Grocott, H.; Mazer, C.D.; Choi, P.T.; Turgeon, A.F.; de Medicis, E.; Bussieres, J.S.; Hudson, C.; Syed, S.; et al. Cerebral Oximetry Monitoring to Maintain Normal Cerebral Oxygen Saturation during High-risk Cardiac Surgery: A Randomized Controlled Feasibility Trial. Anesthesiology 2016, 124, 826–836. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  34. Kara, I.; Erkin, A.; Sacli, H.; Demirtas, M.; Percin, B.; Diler, M.S.; Kirali, K. The Effects of Near-Infrared Spectroscopy on the Neurocognitive Functions in the Patients Undergoing Coronary Artery Bypass Grafting with Asymptomatic Carotid Artery Disease: A Randomized Prospective Study. Ann. Thorac. Cardiovasc. Surg. 2015, 21, 544–550. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  35. Mohandas, B.S.; Jagadeesh, A.M.; Vikram, S.B. Impact of monitoring cerebral oxygen saturation on the outcome of patients undergoing open heart surgery. Ann. Card. Anaesth. 2013, 16, 102–106. [Google Scholar] [CrossRef]
  36. Murkin, J.M.; Adams, S.J.; Novick, R.J.; Quantz, M.; Bainbridge, D.; Iglesias, I.; Cleland, A.; Schaefer, B.; Irwin, B.; Fox, S. Monitoring brain oxygen saturation during coronary bypass surgery: A random- ized, prospective study. Anesth. Analg. 2007, 104, 51–58. [Google Scholar] [CrossRef]
  37. Rogers, C.A.; Stoica, S.; Ellis, L.; Stokes, E.A.; Wordsworth, S.; Dabner, L.; Clayton, G.; Downes, R.; Nicholson, E.; Bennett, S.; et al. Randomized trial of near-infrared spectroscopy for personalized optimization of cerebral tissue oxygenation during cardiac surgery. Br. J. Anaesth. 2017, 119, 384–393. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  38. Slater, J.P.; Guarino, T.; Stack, J.; Vinod, K.; Bustami, R.T.; Brown, J.M., 3rd; Rodriguez, A.L.; Magovern, C.J.; Zaubler, T.; Freundlich, K.; et al. Cerebral oxygen desaturation predicts cognitive decline and longer hospital stay after cardiac surgery. Ann. Thorac. Surg. 2009, 87, 36–44. [Google Scholar] [CrossRef]
  39. Vretzakis, G.; Georgopoulou, S.; Stamoulis, K.; Tassoudis, V.; Mikroulis, D.; Giannoukas, A.; Tsilimingas, N.; Karanikolas, M. Monitoring of brain oxygen saturation (INVOS) in a protocol to direct blood transfusions during cardiac surgery: A prospective randomized clinical trial. J. Cardiothorac. Surg. 2013, 8, 145. [Google Scholar] [CrossRef] [Green Version]
  40. Harilall, Y.; Adam, J.K.; Biccard, B.M.; Reddi, A. The effect of optimising cerebral tissue oxygen saturation on markers of neurological injury during coronary artery bypass graft surgery. Heart, Lung Circ. 2014, 23, 68–74. [Google Scholar] [CrossRef]
  41. Trafidlo, T.; Gaszynski, T.; Gaszynski, W.; Nowakowska-Domagala, K. Intraoperative monitoring of cerebral NIRS oximetry leads to better postoperative cognitive performance: A pilot study. Int. J. Surg. 2015, 16, 23–30. [Google Scholar] [CrossRef]
  42. Yu, Y.; Zhang, K.; Zhang, L.; Zong, H.; Meng, L.; Han, R. Cerebral near-infrared spectroscopy (NIRS) for perioperative monitoring of brain oxygenation in children and adults. Cochrane Database Syst. Rev. 2018, 1, CD010947. [Google Scholar] [CrossRef] [PubMed]
  43. Sterne, J.A.; Sutton, A.J.; Ioannidis, J.P.; Terrin, N.; Jones, D.R.; Lau, J.; Carpenter, J.; Rucker, G.; Harbord, R.M.; Schmid, C.H.; et al. Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. BMJ 2011, 343, d4002. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  44. Terrin, N.; Schmid, C.H.; Lau, J. In an empirical evaluation of the funnel plot, researchers could not visually identify publication bias. J. Clin. Epidemiol. 2005, 58, 894–901. [Google Scholar] [CrossRef] [PubMed]
  45. Ioannidis, J.P. Why most discovered true associations are inflated. Epidemiology 2008, 19, 640–648. [Google Scholar] [CrossRef] [Green Version]
  46. Higgins, J.P.; Thompson, S.G.; Deeks, J.J.; Altman, D.G. Measuring inconsistency in meta-analyses. BMJ 2003, 327, 557–560. [Google Scholar] [CrossRef] [Green Version]
  47. Rothwell, P.M. Subgroup analysis in randomised controlled trials: Importance, indications, and interpretation. Lancet 2005, 365, 176–186. [Google Scholar] [CrossRef]
  48. Deiner, S.; Silverstein, J.H. Postoperative delirium and cognitive dysfunction. Br. J. Anaesth. 2009, 103, i41–i46. [Google Scholar] [CrossRef] [Green Version]
  49. Choi, J.Y.; Kim, K.I.; Kang, M.G.; Lee, Y.K.; Koo, K.H.; Oh, J.H.; Park, Y.H.; Suh, J.; Kim, N.H.; Yoo, H.J.; et al. Impact of a delirium prevention project among older hospitalized patients who underwent orthopedic surgery: A retrospective cohort study. BMC Geriatr. 2019, 19, 289. [Google Scholar] [CrossRef]
  50. Kotfis, K.; Szylinska, A.; Listewnik, M.; Strzelbicka, M.; Brykczynski, M.; Rotter, I.; Zukowski, M. Early delirium after cardiac surgery: An analysis of incidence and risk factors in elderly (>/=65 years) and very elderly (>/=80 years) patients. Clin. Interv. Aging. 2018, 13, 1061–1070. [Google Scholar] [CrossRef] [Green Version]
  51. Lei, L.; Katznelson, R.; Fedorko, L.; Carroll, J.; Poonawala, H.; Machina, M.; Styra, R.; Rao, V.; Djaiani, G. Cerebral oximetry and postoperative delirium after cardiac surgery: A randomised, controlled trial. Anaesthesia 2017, 72, 1456–1466. [Google Scholar] [CrossRef] [Green Version]
  52. Radtke, F.M.; Franck, M.; Lendner, J.; Kruger, S.; Wernecke, K.D.; Spies, C.D. Monitoring depth of anaesthesia in a randomized trial decreases the rate of postoperative delirium but not postoperative cognitive dysfunction. Br. J. Anaesth. 2013, 110, i98–i105. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  53. Murkin, J.M.; Arango, M. Near-infrared spectroscopy as an index of brain and tissue oxygenation. Br. J. Anaesth. 2009, 103, i3–i13. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  54. Vancraeynest, D.; Pasquet, A.; Roelants, V.; Gerber, B.L.; Vanoverschelde, J.L. Imaging the vulnerable plaque. J. Am. Coll. Cardiol. 2011, 57, 1961–1979. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  55. Ehlis, A.C.; Schneider, S.; Dresler, T.; Fallgatter, A.J. Application of functional near-infrared spectroscopy in psychiatry. Neuroimage 2014, 85, 478–488. [Google Scholar] [CrossRef] [PubMed]
  56. Mittnacht, A.J. Near infrared spectroscopy in children at high risk of low perfusion. Curr. Opin. Anaesthesiol. 2010, 23, 342–347. [Google Scholar] [CrossRef] [PubMed]
  57. Denault, A.; Deschamps, A.; Murkin, J.M. A proposed algorithm for the intraoperative use of cerebral near-infrared spectroscopy. Semin. Cardiothorac. Vasc. Anesth. 2007, 11, 274–281. [Google Scholar] [CrossRef]
  58. Taillefer, M.C.; Denault, A.Y. Cerebral near-infrared spectroscopy in adult heart surgery: Systematic review of its clinical efficacy. Can. J. Anaesth. 2005, 52, 79–87. [Google Scholar] [CrossRef] [Green Version]
  59. Pant, S.; Bokor, D.J.; Low, A.K. Cerebral oxygenation using near-infrared spectroscopy in the beach-chair position during shoulder arthroscopy under general anesthesia. Arthroscopy 2014, 30, 1520–1527. [Google Scholar] [CrossRef]
  60. Laflam, A.; Joshi, B.; Brady, K.; Yenokyan, G.; Brown, C.; Everett, A.; Selnes, O.; McFarland, E.; Hogue, C.W. Shoulder surgery in the beach chair position is associated with diminished cerebral autoregulation but no differences in postoperative cognition or brain injury biomarker levels compared with supine positioning: The anesthesia patient safety foundation beach chair study. Anesth. Analg. 2015, 120, 176–185. [Google Scholar] [CrossRef] [Green Version]
  61. Chan, M.J.; Chung, T.; Glassford, N.J.; Bellomo, R. Near-Infrared Spectroscopy in Adult Cardiac Surgery Patients: A Systematic Review and Meta-Analysis. J. Cardiothorac. Vasc. Anesth. 2017, 31, 1155–1165. [Google Scholar] [CrossRef] [Green Version]
  62. Montisci, A.; Travaglini, S.; Miceli, A. The lack of a magic bullet. J. Thorac. Cardiovasc. Surg. 2018. [Google Scholar] [CrossRef]
  63. Walker, I.A.; Reshamwalla, S.; Wilson, I.H. Surgical safety checklists: Do they improve outcomes? Br. J. Anaesth. 2012, 109, 47–54. [Google Scholar] [CrossRef] [Green Version]
  64. Hammon, J.W. Brain Protection during Cardiac Surgery: Circa 2012. JECT 2013, 45, 116–121. [Google Scholar]
  65. Yuan, S.M. S100 and S100beta: Biomarkers of cerebral damage in cardiac surgery with or without the use of cardiopulmonary bypass. Rev. Bras. Cir. Cardiovasc. 2014, 29, 630–641. [Google Scholar] [CrossRef] [Green Version]
  66. Reinsfelt, B.; Ricksten, S.E.; Zetterberg, H.; Blennow, K.; Freden-Lindqvist, J.; Westerlind, A. Cerebrospinal fluid markers of brain injury, inflammation, and blood-brain barrier dysfunction in cardiac surgery. Ann. Thorac. Surg. 2012, 94, 549–555. [Google Scholar] [CrossRef]
  67. Silva, F.P.; Schmidt, A.P.; Valentin, L.S.; Pinto, K.O.; Zeferino, S.P.; Oses, J.P.; Wiener, C.D.; Otsuki, D.A.; Tort, A.B.; Portela, L.V.; et al. S100B protein and neuron-specific enolase as predictors of cognitive dysfunction after coronary artery bypass graft surgery: A prospective observational study. Eur. J. Anaesthesiol. 2016, 33, 681–689. [Google Scholar] [CrossRef]
  68. Lindblom, R.P.F.; Shen, Q.; Axen, S.; Landegren, U.; Kamali-Moghaddam, M.; Thelin, S. Protein Profiling in Serum and Cerebrospinal Fluid Following Complex Surgery on the Thoracic Aorta Identifies Biological Markers of Neurologic Injury. J. Cardiovasc. Transl. Res. 2018, 11, 503–516. [Google Scholar] [CrossRef] [Green Version]
  69. Olbrecht, V.A.; Skowno, J.; Marchesini, V.; Ding, L.; Jiang, Y.; Ward, C.G.; Yu, G.; Liu, H.; Schurink, B.; Vutskits, L.; et al. An International, Multicenter, Observational Study of Cerebral Oxygenation during Infant and Neonatal Anesthesia. Anesthesiology 2018, 128, 85–96. [Google Scholar] [CrossRef]
  70. Ortega-Loubon, C.; Fierro, I.; Tamayo, E. Should kidney oxygen saturation be monitored to prevent acute kidney injury after adult cardiac surgery? J. Thorac. Cardiovasc. Surg. 2019. [Google Scholar] [CrossRef] [Green Version]
Jcm 08 02208 g001 550
Figure 1. Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) flowchart representing systematic-review selection process.
Figure 1. Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) flowchart representing systematic-review selection process.
Jcm 08 02208 g001
Jcm 08 02208 g002 550
Figure 2. Effect of NIRS monitoring on postoperative cognitive decline/delirium. (A) Forest plot and (B) funnel plot. CI, confidence interval; M–H, Mantel–Haenszel test; NORMOSAT, normal cerebral oxygen saturation; PASPORT, Patient-Specific Cerebral Oxygenation Monitoring as Part of an Algorithm to Reduce Transfusion during Heart Valve Surgery: A Randomized Controlled Trial; SE, standard error; and SOC, standard of care.
Figure 2. Effect of NIRS monitoring on postoperative cognitive decline/delirium. (A) Forest plot and (B) funnel plot. CI, confidence interval; M–H, Mantel–Haenszel test; NORMOSAT, normal cerebral oxygen saturation; PASPORT, Patient-Specific Cerebral Oxygenation Monitoring as Part of an Algorithm to Reduce Transfusion during Heart Valve Surgery: A Randomized Controlled Trial; SE, standard error; and SOC, standard of care.
Jcm 08 02208 g002
Jcm 08 02208 g003 550
Figure 3. League table presenting all assessable NIRS target values for outcome of postoperative cognitive decline/delirium. bSo2, brain-oxygen saturation.
Figure 3. League table presenting all assessable NIRS target values for outcome of postoperative cognitive decline/delirium. bSo2, brain-oxygen saturation.
Jcm 08 02208 g003
Jcm 08 02208 g004 550
Figure 4. Network diagram and forest plot of competing NIRS target values for outcome of postoperative cognitive decline/delirium. CrI, credible interval; OR, odds ratio.
Figure 4. Network diagram and forest plot of competing NIRS target values for outcome of postoperative cognitive decline/delirium. CrI, credible interval; OR, odds ratio.
Jcm 08 02208 g004
Table
Table 1. Review questions and study eligibility.
Table 1. Review questions and study eligibility.
Explanations
Review questionWhich perioperative NIRS target values were most adequate for patients who underwent major surgical procedures?
Participants/populationAdult and pediatric individuals who underwent major cardiac or noncardiac surgery.
Intervention(s)/exposures(s)Perioperative near-infrared spectroscopy target values according to current algorithms.
ComparatorsNo brain-oxygenation monitoring or brain-oxygenation monitoring based on non-NIRS technologies.
Note: NIRS, near-infrared spectroscopy.

Share and Cite

MDPI and ACS Style

Ortega-Loubon, C.; Herrera-Gómez, F.; Bernuy-Guevara, C.; Jorge-Monjas, P.; Ochoa-Sangrador, C.; Bustamante-Munguira, J.; Tamayo, E.; Álvarez, F.J. Near-Infrared Spectroscopy Monitoring in Cardiac and Noncardiac Surgery: Pairwise and Network Meta-Analyses. J. Clin. Med. 2019, 8, 2208. https://doi.org/10.3390/jcm8122208

AMA Style

Ortega-Loubon C, Herrera-Gómez F, Bernuy-Guevara C, Jorge-Monjas P, Ochoa-Sangrador C, Bustamante-Munguira J, Tamayo E, Álvarez FJ. Near-Infrared Spectroscopy Monitoring in Cardiac and Noncardiac Surgery: Pairwise and Network Meta-Analyses. Journal of Clinical Medicine. 2019; 8(12):2208. https://doi.org/10.3390/jcm8122208

Chicago/Turabian Style

Ortega-Loubon, Christian, Francisco Herrera-Gómez, Coralina Bernuy-Guevara, Pablo Jorge-Monjas, Carlos Ochoa-Sangrador, Juan Bustamante-Munguira, Eduardo Tamayo, and F. Javier Álvarez. 2019. "Near-Infrared Spectroscopy Monitoring in Cardiac and Noncardiac Surgery: Pairwise and Network Meta-Analyses" Journal of Clinical Medicine 8, no. 12: 2208. https://doi.org/10.3390/jcm8122208

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop